Onderneming Adaptimmune Therapeutics plc
Aandelen
ADAP
US00653A1079
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,57 USD | -0,63% | +17,16% | +97,98% |
Vakgebied
Aantal werknemers: 449
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Cell Therapies
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +122,05% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +122,05% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 57 | 01-01-08 | |
Adrian Rawcliffe
CEO | Chief Executive Officer | 52 | 01-03-15 |
Gavin Wood
DFI | Director of Finance/CFO | 54 | 01-04-20 |
Joanna Brewer
CTO | Chief Tech/Sci/R&D Officer | 47 | 01-01-09 |
Elliot Norry
CTO | Chief Tech/Sci/R&D Officer | 61 | 01-07-15 |
William Bertrand
COO | Chief Operating Officer | 59 | 15-03-17 |
Juli P. Miller
IRC | Investor Relations Contact | - | 01-08-16 |
Sharp Kerry
LAW | General Counsel | - | 01-10-15 |
Phil Bassett
PRN | Corporate Officer/Principal | - | - |
John Lunger
PRN | Corporate Officer/Principal | 55 | 01-03-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 01/11 |
Andrew Allen
BRD | Director/Board Member | 57 | 01-06-23 |
David Mott
CHM | Chairman | 58 | 01-09-14 |
Adrian Rawcliffe
CEO | Chief Executive Officer | 52 | 01-03-15 |
Ali Behbahani
BRD | Director/Board Member | 47 | 01-09-14 |
Garry Menzel
BRD | Director/Board Member | 59 | 01-06-23 |
John Furey
BRD | Director/Board Member | 59 | 05-07-18 |
Lawrence Alleva
BRD | Director/Board Member | 74 | 01-03-15 |
Priti Hegde
BRD | Director/Board Member | 52 | 01-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 480 950 456 | 223 044 163 ( 15,06 %) | 0 | 15,06 % |
Bedrijfsgegevens
Adaptimmune Therapeutics Plc
60 Jubilee Avenue Milton Park
OX14 4RX, Abingdon
+44 12 3543 0000
http://www.adaptimmune.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+97,98% | 390 mln. | |
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-35,36% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |
- Beurs
- Aandelen
- Aandeel Adaptimmune Therapeutics plc - Nasdaq
- Onderneming Adaptimmune Therapeutics plc